KKM Global Group Announces Strategic Term Sheet with Visionary Oncology and OncoSphere Health Solutions (OHS)

The Villages, FL — KKM Global is pleased to announce the execution of a strategic term sheet with OncoSphere Health Solutions (OHS). This agreement marks a pivotal step toward advancing the availability and innovation of radiotherapy and molecular imaging solutions globally.

OHS, renowned for its expertise in oncology and molecular imaging operations, will combine its clinical insights and technical expertise with its leadership in radiotherapy and oncology project development to deliver state-of-the-art solutions to healthcare providers worldwide.

Key highlights of the agreement include:

• Collaborative Expertise: OHS will contribute intellectual property, know-how, and operational management services to support radiotherapy, oncology, and theranostics projects.

• Innovative Projects: The partnership will focus on deploying advanced radiotherapy and molecular imaging systems, including cutting-edge radiosurgery technology from Akesis, a leading provider of integrated radiotherapy and radiosurgery systems.

• Strategic Leadership: A newly established five-member board of directors will oversee the collaboration, ensuring alignment with shared goals and sustainable growth.

“OHS’s vision aligns perfectly with our goal of expanding access to high-quality care,” said Leonard A. Farber, MD, Chief Executive Officer of OHS. “This partnership represents a significant leap forward in our mission to revolutionize oncology care. By leveraging our expertise alongside Akesis’s state-of-the-art technology, we are poised to deliver groundbreaking solutions that improve outcomes for patients worldwide.”

This strategic partnership underscores the commitment of KKM Global and OHS to jointly develop innovative radiotherapy solutions while fostering growth in the healthcare market.

About OHS

OncoSphere Health Solutions (OHS) is a leader in delivering comprehensive oncology solutions, spanning financing, site development, advanced radiotherapy equipment, theranostic technologies, isotope supply, revenue cycle optimization, and clinician education. Through its turnkey program, OHS is committed to enhancing radiotherapy and oncology services worldwide.